Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,038 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Understanding The Food Recall Procedure Regulations, 2017

    Food safety is a paramount concern for consumers and regulators alike. As global trade expands and supply chains grow more complex, ensuring that the food on our plates is safe has become an essential function...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    When "Slightest Possibility" Meets Burden Of Proof: Delhi High Court's Bevatas v. Bevetex Ruling

    In a recent ruling concerning trademark infringement in pharmaceuticals, a Division Bench of the Delhi High Court set aside a permanent injunction that restrained Intas Pharmaceuticals from selling its anti-cancer drug under the mark BEVATAS. The decision is significant for two reasons. First, it pushes back against the principle of “even the slightest possibility of confusion” which is standard in pharmaceutical cases due to the Supreme Court’s ruling in Cadila Healthcare (2001).
    IndiaFood, Drugs, Healthcare, Life Sciences
S.S. Rana & Co.
S.S. Rana & Co.
  • Article

    Why Public Auction Cancellations Are Under Stricter Judicial Scrutiny

    Public auctions by States, development authorities, housing boards and PSUs are central to monetizing land, natural resources and public assets, and auction terms usually preserve a wide "right to cancel" in favour of the Authority.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Legitpro Law
    Legitpro Law
  • Article

    Innovative Relationship Of Patents & Business Entities During Crisis

    Intellectual property has always driven business entities around the globe to innovate and prove its mark in the dynamic environment.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Patent Wars: The Global Patent Battle Over Vyndamax

    Recently, Madras High Court pronounced an order relating to an ongoing patent dispute in the United States. Pfizer, a pharmaceutical giant has patented "VYNDAMAX" aka "TAFAMIDIS", a drug used to treat a heart condition.
    IndiaIntellectual Property
    Naik Naik & Company
    Naik Naik & Company
  • Article

    Pharma Companies Extend Patent Life With Slight Modifications

    Since drug development carries unknown risks and extensive research and development which consumes several years.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Pharma Companies Extent Patent Life With Slight Modifications

    Pharmaceutical industry is one of the most potential industry which has huge profit margins.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    The Evolution Of Patent Law In The Pharmaceutical Industry

    Intellectual Property refers to the creations of the human mind while intellectual property rights simply refer to those rights that protect creations of the human mind
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Trips Plus And Biodrugs: Imperative Poise Between IP Fundamentalism And Access To Biodrugs

    It encompasses vaccines, insulin, monoclonal antibodies, therapeutic proteins and gene therapy products.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Defining Safety In Food Contact Materials: Analysis Of The Draft Food Safety And Standards (Packaging) Amendment Regulations, 2026

    The regulation of food packaging materials represents a critical frontier in food safety governance, as the integrity of packaging directly impacts both the preservation of food quality and the prevention...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Drugs, Medical Devices And Cosmetics Bill, 2023: An Attempt At Modernizing The Regime Governing Medical Products

    The Drugs, Medical Devices and Cosmetics Bill, 2023 (the "Drugs Bill") seeks to replace the Drugs and Cosmetics Act, 1940 (the "Drugs Act")...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Majmudar & Partners
    Majmudar & Partners
  • Article

    Regulating The Price Of Health: A Legal Analysis Of India’s 2026 Drug Ceiling Price Notification

    On March 25, 2026, the National Pharmaceutical Pricing Authority (NPPA), operating under the aegis of the Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals), Government of India...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    India And USTR Priority Watch List: 15 Years Of Friction And Whether The EU FTA Changes The Equation

    India has remained on the US Trade Representative's Priority Watch List for over 15 years due to ongoing disputes over intellectual property protection, particularly concerning pharmaceutical patents, compulsory licensing, and data exclusivity. With the recent India-EU Free Trade Agreement signed in January 2026, questions arise about whether this landmark deal will alter the dynamics of US-India trade negotiations and India's controversial IP stance.
    IndiaInternational Law
    Maheshwari & Co. Advocates & Legal Consultants
    Maheshwari & Co. Advocates & Legal Consultants
  • Article

    Failure To Conduct Enquiry Under Section 202 Of The Code Of Criminal Procedure, 1973 Does Not Vitiate Complaint Filed By Public Servant; Limitation Runs From Discovery Of Offender

    The Supreme Court of India (“Supreme Court”) in the case of The State of Kerala vs. M/s Panacea Biotec Limited and Anr. considered whether criminal proceedings under the Drugs and Cosmetics Act, 1940 could be quashed on the ground that the Magistrate failed to conduct an enquiry under Section 202 of the Code of Criminal Procedure, 1973 (“CrPC”), and whether cognisance was barred by limitation under Sections 468 and 469 of the CrPC.
    IndiaLitigation, Mediation & Arbitration
    JSA Advocates & Solicitors
    JSA Advocates & Solicitors
  • Article

    Towards Uniform Vegan Labelling In India: Legal And Regulatory Implications Of The 2026 FSSAI Amendment

    India's food safety regulator has introduced mandatory vegan labelling standards requiring a uniform green logo on all plant-based food products. The new regulations establish precise technical specifications for the visual...
    IndiaConsumer Protection
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    A Drug Pill Which Could Change How Medicines Will Be Priced Forever

    Assume your doctor prescribes a drug to you. The brand-name version costs $300 a month. Another generic drug on the other hand will cost $30. As most people would, you would also purchase the cheaper one. That generic cheaper bottle exists as a result of a delicate legal balancing act, an act that the U.S. Supreme Court is now reconsidering in a case that could change pharmaceutical competition for decades.
    IndiaFood, Drugs, Healthcare, Life Sciences
    LegaLogic
    LegaLogic
  • Article

    CDSCO Advises Strict Regulation Of Oxytocin To Curb Its Misuse

    Oxytocin also known as love-hormone as it plays a role in the female reproductive functions including sexual activity, child birth and maternal nurturing behavior along with general psychological stability.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    FDA Intensifies Its Warning Against Kratom, Classifying It As An ‘Opioid' Underscoring Potential For Abuse

    On February 06, 2018, the US-FDA intensified its warnings about Kratom, stating that new research provides strong evidence that the unregulated botanical substance has ‘opioid properties'.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Healing The Future: Indian Startups Paving The Way Through Technology And Innovation

    Medical and Healthcare Technology ("MedTech") is a sunrise sector in the Indian economy, with startups and MNCs growing at rapid pace with an estimated growth from US$ 11 billion to US$ 50 billion by 2030 at 16.4% CAGR.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Karnataka's 2025 Tobacco Law Overhaul: What It Means For Businesses And Citizens

    On May 30, 2025, the Government of Karnataka notified the Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Showing 681–700 of 1038 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics